Literature DB >> 8567157

Consolidation of massive bone allografts in limb-preserving operations for bone tumours.

M San Julian Aranguren1, M Leyes, G Mora, J Cañadell.   

Abstract

This study analysed the influence of several factors affecting the consolidation time of 83 massive bone allografts in 79 patients with malignant bone tumours: osteosarcoma 57; Ewing's sarcoma 8; malignant fibrous histiocytoma 3; chondrosarcoma 4; fibrosarcoma 5; and giant cell tumours 2. The mean age of the patients was 19 years and the mean length of the allografts was 18 cm. The minimum follow up was for 12 months. The mean consolidation time for metaphyseal and diaphyseal osteotomies was 6.5 and 16 months respectively. Fifteen diaphyseal osteotomies required autologous cancellous grafting. There were 8 allograft fractures after consolidation. The following factors which might influence consolidation were analysed: age of the host and donor; allograft length and site; type of osteotomy and osteosynthesis; intra-arterial and systemic chemotherapy; intraoperative and external radio-therapy. In diaphyseal osteotomies there were statistically significant differences in consolidation time with the use of systemic chemotherapy, external radiotherapy and the recipient's age.

Entities:  

Mesh:

Year:  1995        PMID: 8567157     DOI: 10.1007/bf00178354

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  43 in total

1.  The significance of scoliosis in postirradiated Wilms's tumor and neuroblastoma.

Authors:  P RUBIN; R B DUTHIE; L W YOUNG
Journal:  Radiology       Date:  1962-10       Impact factor: 11.105

2.  Osseous damage in irradiation of renal tumors in infancy and childhood.

Authors:  W M WHITEHOUSE; I LAMPE
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1953-11

3.  Massive bone allografts in children.

Authors:  R Kohler; F Lorge; M Brunat-Mentigny; D Noyer; L Patricot
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

4.  Osteoarticular and intercalary allograft transplantation in the management of malignant tumors of bone.

Authors:  H J Mankin; S H Doppelt; T R Sullivan; W W Tomford
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

5.  The effects of cisplatin on the incorporation of fresh syngeneic and frozen allogeneic cortical bone grafts.

Authors:  D J Zart; L Miya; D A Wolff; J T Makley; S Stevenson
Journal:  J Orthop Res       Date:  1993-03       Impact factor: 3.494

6.  Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.

Authors:  G Bacci; P Picci; P Ruggieri; M Mercuri; M Avella; R Capanna; A Brach Del Prever; A Mancini; F Gherlinzoni; G Padovani
Journal:  Cancer       Date:  1990-06-01       Impact factor: 6.860

7.  The effect of chemotherapy on soft tissue and bone healing in the rabbit model.

Authors:  D B Khoo
Journal:  Ann Acad Med Singapore       Date:  1992-03       Impact factor: 2.473

8.  Allograft transplantation in aggressive or malignant bone tumors.

Authors:  J W Wang; C H Shih
Journal:  Clin Orthop Relat Res       Date:  1993-12       Impact factor: 4.176

9.  Fractures in large-segment allografts.

Authors:  R C Thompson; E A Pickvance; D Garry
Journal:  J Bone Joint Surg Am       Date:  1993-11       Impact factor: 5.284

Review 10.  Current status of allografting for bone tumors.

Authors:  H J Mankin; D S Springfield; M C Gebhardt; W W Tomford
Journal:  Orthopedics       Date:  1992-10       Impact factor: 1.390

View more
  10 in total

Review 1.  Limb salvage in the skeletally immature patient.

Authors:  Valerae O Lewis
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.075

Review 2.  [Tissue engineering of bone tissue. Principles and clinical applications].

Authors:  B Schmidt-Rohlfing; C Tzioupis; C L Menzel; H C Pape
Journal:  Unfallchirurg       Date:  2009-09       Impact factor: 1.000

Review 3.  Intercalary reconstructions after bone tumor resections: a review of treatments.

Authors:  Georgios N Panagopoulos; Andreas F Mavrogenis; Cyril Mauffrey; Jan Lesenský; Andrea Angelini; Panayiotis D Megaloikonomos; Vasilios G Igoumenou; John Papanastassiou; Olga Savvidou; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

4.  Massive allografts in tumour surgery.

Authors:  Z Matejovsky; Z Matejovsky; I Kofranek
Journal:  Int Orthop       Date:  2006-09-30       Impact factor: 3.075

5.  Custom-made intercalary endoprosthetic reconstruction for a parosteal osteosarcoma of the femoral diaphysis: A case report.

Authors:  Shi-Chang Zhao; Chang-Qing Zhang; Chun-Lin Zhang
Journal:  Oncol Lett       Date:  2015-08-24       Impact factor: 2.967

6.  Endoprosthetic replacement of diaphyseal bone defects. Long-term results.

Authors:  E Aldlyami; A Abudu; R J Grimer; S R Carter; R M Tillman
Journal:  Int Orthop       Date:  2005-01-05       Impact factor: 3.075

7.  Extracorporeal irradiated tumor bone: A reconstruction option in diaphyseal Ewing's sarcomas.

Authors:  Ajay Puri; Ashish Gulia; Mg Agarwal; Na Jambhekar; S Laskar
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

8.  Structural bone allograft fractures in oncological procedures.

Authors:  Javier Garcia-Coiradas; Roberto Garcia-Maroto; Juan Luis Cebrian; Luis Lopez-Duran
Journal:  Int Orthop       Date:  2015-09-03       Impact factor: 3.075

9.  Intercalary reconstructions with vascularised fibula and allograft after tumour resection in the lower limb.

Authors:  Katharina Rabitsch; Werner Maurer-Ertl; Ulrike Pirker-Frühauf; Christine Wibmer; Andreas Leithner
Journal:  Sarcoma       Date:  2013-05-23

10.  Short-term outcomes of reconstruction subsequent to intercalary resection of femoral diaphyseal metastatic tumor with pathological fracture: Comparison between segmental allograft and intercalary prosthesis.

Authors:  Deng-Xing Lun; Yong-Cheng Hu; Xiong-Gang Yang; Feng Wang; Zhao-Wan Xu
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.